TR199800146T1 - Karbapenem antibiotik,terkibi ve haz�rlama y�ntemi. - Google Patents
Karbapenem antibiotik,terkibi ve haz�rlama y�ntemi.Info
- Publication number
- TR199800146T1 TR199800146T1 TR1998/00146T TR9800146T TR199800146T1 TR 199800146 T1 TR199800146 T1 TR 199800146T1 TR 1998/00146 T TR1998/00146 T TR 1998/00146T TR 9800146 T TR9800146 T TR 9800146T TR 199800146 T1 TR199800146 T1 TR 199800146T1
- Authority
- TR
- Turkey
- Prior art keywords
- composition
- preparation
- carbapenem antibiotic
- carbapenem
- antibiotic
- Prior art date
Links
- 230000003115 biocidal effect Effects 0.000 title 1
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical compound C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 abstract 2
- 229910002092 carbon dioxide Inorganic materials 0.000 abstract 1
- 239000001569 carbon dioxide Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D499/887—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with a hetero atom or a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1851896P | 1996-05-28 | 1996-05-28 | |
| GBGB9612668.5A GB9612668D0 (en) | 1996-06-18 | 1996-06-18 | Carbapenem antibiotic composition and method of preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR199800146T1 true TR199800146T1 (xx) | 1998-06-22 |
Family
ID=26309530
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR1998/00146T TR199800146T1 (xx) | 1996-05-28 | 1997-05-23 | Karbapenem antibiotik,terkibi ve haz�rlama y�ntemi. |
Country Status (33)
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0937079A4 (en) * | 1996-10-28 | 2001-01-24 | Merck & Co Inc | STABILIZED ANTIBIOTIC CARBAPENEM COMPOSITIONS AND A METHOD FOR THEIR PRODUCTION |
| US6180783B1 (en) * | 1997-06-16 | 2001-01-30 | Merck & Co., Inc. | Stabilized carbapenem intermediates and improved process for carbapenem synthesis |
| WO1998057973A1 (en) * | 1997-06-16 | 1998-12-23 | Merck & Co., Inc. | Stabilized carbapenem intermediates and synthetic use |
| US6504027B1 (en) | 1998-03-02 | 2003-01-07 | Merck & Co., Inc. | Decarboxylation process for synthesizing carbapenem antibiotics |
| DE60017194T2 (de) * | 1999-10-29 | 2005-12-22 | Merck & Co., Inc. | Verfahren zur herstellung von carbapenem-antibiotika zubereitungen |
| AR035728A1 (es) | 2001-01-16 | 2004-07-07 | Merck & Co Inc | Proceso perfeccionado para la sintesis de carbapenem |
| CN101357918B (zh) * | 2007-06-22 | 2011-05-18 | 山东轩竹医药科技有限公司 | 含有异硫脲基巯基吡咯烷的培南衍生物 |
| CN101367815B (zh) * | 2007-06-28 | 2012-07-04 | 山东轩竹医药科技有限公司 | 六元环甲酰胺取代的巯基吡咯烷碳青霉烯化合物 |
| WO2009075309A1 (ja) | 2007-12-12 | 2009-06-18 | Dainippon Sumitomo Pharma Co., Ltd. | 製剤組成物 |
| CN101550138B (zh) * | 2008-04-03 | 2011-05-18 | 山东轩竹医药科技有限公司 | 巯基氮杂环烷酰胺醇取代的培南衍生物 |
| WO2009150630A2 (en) * | 2008-06-11 | 2009-12-17 | Ranbaxy Laboratories Limited | Process for preparing a carbapenem antibiotic composition |
| CN102365266B (zh) | 2009-03-31 | 2013-11-06 | 三菱综合材料株式会社 | 含氟n-烷基磺酰亚胺化合物及其制造方法、以及离子性化合物的制造方法 |
| BRPI1014338B1 (pt) | 2009-06-25 | 2019-12-24 | Shell Int Research | método para injetar água em uma formação contendo hidrocarbonetos, e, método para preparar uma água com salinidade elevada |
| WO2012047832A2 (en) | 2010-10-07 | 2012-04-12 | Shell Oil Company | Process for the production of alcohols from biomass |
| WO2012061596A1 (en) | 2010-11-05 | 2012-05-10 | Shell Oil Company | Treating biomass to produce materials useful for biofuels |
| WO2012088108A1 (en) | 2010-12-20 | 2012-06-28 | Shell Oil Company | Process for the production of alcohols from biomass |
| EP2791344B1 (en) | 2011-12-15 | 2016-02-24 | Shell Internationale Research Maatschappij B.V. | Method of treating byproducts from ethanol production |
| US20130309739A1 (en) | 2012-05-17 | 2013-11-21 | Shell Oil Company | Methods and systems for processing biomass material |
| CN103860485A (zh) * | 2012-12-18 | 2014-06-18 | 深圳市海滨制药有限公司 | 一种厄他培南钠冻干制剂及其制备方法 |
| EP3132045A1 (en) | 2014-04-17 | 2017-02-22 | Shell Internationale Research Maatschappij B.V. | Processes for producing fermentation products |
| EP3180320B1 (en) | 2014-08-14 | 2021-01-13 | Shell International Research Maatschappij B.V. | Process for preparing furfural from biomass |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES8502863A1 (es) * | 1982-09-10 | 1985-02-01 | Glaxo Group Ltd | Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama. |
| GB9202298D0 (en) * | 1992-02-04 | 1992-03-18 | Ici Plc | Antibiotic compounds |
| CA2091309A1 (en) * | 1992-03-26 | 1993-09-27 | Frederic H. Jung | Antibiotic compounds |
-
1997
- 1997-05-21 HR HR970281A patent/HRP970281B1/xx not_active IP Right Cessation
- 1997-05-23 KR KR10-2001-7008925A patent/KR100403497B1/ko not_active Expired - Lifetime
- 1997-05-23 DE DE69725696T patent/DE69725696T2/de not_active Expired - Lifetime
- 1997-05-23 EE EE9800022A patent/EE04678B1/xx unknown
- 1997-05-23 KR KR1019980700717A patent/KR100344479B1/ko not_active Expired - Lifetime
- 1997-05-23 IL IL12307897A patent/IL123078A/en not_active IP Right Cessation
- 1997-05-23 HU HU9901567A patent/HU229426B1/hu unknown
- 1997-05-23 ES ES97925725T patent/ES2208907T3/es not_active Expired - Lifetime
- 1997-05-23 SI SI9730603T patent/SI0863901T1/xx unknown
- 1997-05-23 RS YUP-41/98A patent/RS49583B/sr unknown
- 1997-05-23 PL PL97324746A patent/PL188917B1/pl unknown
- 1997-05-23 CN CN97190911A patent/CN1067074C/zh not_active Expired - Lifetime
- 1997-05-23 NZ NZ329649A patent/NZ329649A/en not_active IP Right Cessation
- 1997-05-23 MX MX9800808A patent/MX9800808A/es active IP Right Grant
- 1997-05-23 WO PCT/US1997/008831 patent/WO1997045430A1/en not_active Ceased
- 1997-05-23 EP EP97925725A patent/EP0863901B1/en not_active Expired - Lifetime
- 1997-05-23 EA EA199800180A patent/EA000534B1/ru not_active IP Right Cessation
- 1997-05-23 PT PT97925725T patent/PT863901E/pt unknown
- 1997-05-23 CZ CZ0025398A patent/CZ296381B6/cs not_active IP Right Cessation
- 1997-05-23 CA CA002227994A patent/CA2227994C/en not_active Expired - Lifetime
- 1997-05-23 AU AU30775/97A patent/AU710102B2/en not_active Expired
- 1997-05-23 AT AT97925725T patent/ATE252584T1/de active
- 1997-05-23 DK DK97925725T patent/DK0863901T3/da active
- 1997-05-23 JP JP9542800A patent/JPH11509871A/ja not_active Withdrawn
- 1997-05-23 TR TR1998/00146T patent/TR199800146T1/xx unknown
- 1997-05-23 SK SK109-98A patent/SK284359B6/sk not_active IP Right Cessation
- 1997-05-26 CO CO97028781A patent/CO4940412A1/es unknown
- 1997-05-26 ID IDP971736A patent/ID16974A/id unknown
- 1997-05-27 DZ DZ970091A patent/DZ2242A1/fr active
- 1997-05-28 TW TW086107254A patent/TW434014B/zh not_active IP Right Cessation
-
1998
- 1998-01-27 IS IS4663A patent/IS2353B/is unknown
- 1998-01-28 NO NO19980380A patent/NO323815B1/no not_active IP Right Cessation
- 1998-02-24 BG BG102273A patent/BG63821B1/bg unknown
-
2004
- 2004-04-26 CY CY0400030A patent/CY2437B1/xx unknown
-
2008
- 2008-10-17 JP JP2008268213A patent/JP5255983B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT863901E (pt) | Antibiotico carbapenem composicao e metodo de preparacao | |
| AU6645998A (en) | Oxygen or sulfur containing heteroaromatics as factor xa inhibitors | |
| NZ333385A (en) | Solid oral dosage forms containing 35% of valsartan | |
| DE69720551D1 (de) | Makrozyklische derivate von erythromycin a und b mit 13 ringatomen | |
| AU5669298A (en) | Cyclosporin derivatives, their preparation and pharmaceutical compositions containing them | |
| AU7077894A (en) | Immunosuppressant and antiallergic compounds, e.g. n-(3-oxohexanoyl) homoserine lactone | |
| AU5669398A (en) | Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them | |
| AU8156394A (en) | Methods for inhibiting LDL oxidation and atheroclerosis | |
| UA29435C2 (uk) | Похідні 3бета-алкенілпенаму та їх фармацевтично прийнятні солі | |
| ZA974573B (en) | Carbapenem antibiotic, composition and method of preparation. | |
| AU5727899A (en) | Diaminocyclobutene-3,4-dione derivatives, their preparation and use | |
| BG101884A (en) | Salts of the clavulanic acid | |
| IL76345A0 (en) | Proline derivatives and antihypertensive and anti-glaucoma pharmaceutical preparations containing the same | |
| IE893578L (en) | Phenyloxypropanolamine derivatives, their preparation and¹their application in therapeutics | |
| MY116202A (en) | Carbapenem antibiotic, composition and method of preparation | |
| CA2162761A1 (en) | Antineoplastic cyclolignan derivatives | |
| ECSP972136A (es) | Composicion y metodo de preparacion de un antibiotico de carbapemen | |
| AU3091795A (en) | Inhibition of leukotriene biosynthesis with urea derivatives |